A new market study, titled “Liquid Biopsy – Global Market Outlook (2017-2023)”, has been featured on WiseGuyReports.
According to research study, the Global Liquid Biopsy market is expected to grow from $310.0 million in 2016 to reach $1201.52 million by 2023 with a CAGR of 21.3%. Increasing research & developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. On the other hand, higher costs and complex regulations are restraining the market growth.
Liquid biopsy tests are used to help find cancer at an early stage. These tests are performed to interpret the molecular aspects of cancer across the healthcare and research settings, such as research laboratories, physicians, pathological and hospitals. The circulating tumor cells leads the market globally with the largest market share and is expected to grow with a highest CAGR during the forecast period. By cancer type, lung cancer segment is expected to witness high growth rate during the forecast period. North America emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S.
Some of the key players in global liquid biopsy market include Roche Diagnostics, Guardant Health, Inc, Illumina, Inc, Biocept, Inc, Myriad Genetics, Inc, Qiagen N.V. , Genomic Health, Inc
Thermo Fisher Scientific Inc , Bio-Rad Laboratories, Inc, Epic Sciences, Exosome, Cynvenio
Guardant Health, Personal Genome Diagnostics and Janssen Diagnostics, LLC.
Clinical Applications Covered:
- Treatment Monitoring
- Recurrence Monitoring
- Early Cancer Screening
- Therapy Selection
Product and Services Covered:
- Platforms & Instruments
- Assay Kits & Reagents
- Services
Cancer Types Covered:
- Breast Cancer
- Liver Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Other Cancer Types
Circulating Biomarkers Covered:
- Circulating Tumor DNA (CTDNA)
- Extracellular Vesicles (Evs)
- Circulating Tumor Cells
- Cell-Free DNA
- Exosomes
- Other Circulating Biomarkers
Request Sample Report at https://www.wiseguyreports.com/sample-request/2768991-liquid-biopsy-global-market-outlook-2017-2023
Sample Types Covered:
- Urine
- Blood
- Other Sample Types
End Users Covered:
- Academic and Research Centers
- Hospitals and Physician Laboratories
- Diagnostic centres & Reference Laboratories
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
- South America
o Argentina
o Brazil
o Chile
o Rest of South America
- Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Liquid Biopsy Market, By Clinical Application
6 Global Liquid Biopsy Market, By Product and Service
7 Global Liquid Biopsy Market, By Cancer Type
8 Global Liquid Biopsy Market, By Circulating Biomarker
9 Global Liquid Biopsy Market, By Sample Type
10 Global Liquid Biopsy Market, By End User
11 Global Smart Lock Market, By Geography
12 Key Developments
13 Company Profiling
13.1 Roche Diagnostics
13.2 Guardant Health, Inc
13.3 Illumina, Inc
13.4 Biocept, Inc.
13.5 Myriad Genetics, Inc
13.6 Qiagen N.V.
13.7 Genomic Health, Inc
13.8 Thermo Fisher Scientific Inc
13.9 Bio-Rad Laboratories, Inc
13.10 Epic Sciences
13.11 Exosome
13.12 Cynvenio
13.13 Guardant Health
13.14 Personal Genome Diagnostics
13.15 Janssen Diagnostics, LLC.
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.